Auriga downgraded ViroPharma from Buy to Hold, maintaining its price target of $34.
49731
Auriga downgraded ViroPharma (vphm) to Hold;
87396
Oppenheimer downgrades ANSYS Inc. to Perform
64947
Pharmasset publicly offers $92.8 million in stock
161839
Fitch downgrades Alliance & Leicester
136847
Goldman Sachs downgrades Healthways Inc. (hway) to Sell
146037
Citi downgrades Areva T&D to 'hold'
166693
Fitch downgrades ICCREA Holding to 'a';
155478
Wedbush downgrades Polaris (pii) to Hold
116265
Orica shares punished as profit falls
146531
Prada cuts final price for IPO
134858
Copper reverses gains after jump in inventories
2645
Finisar (FNSR) downgraded by credit Suisse
3849
Gold prices slide below $1,680
149160
Jefferies downgrades Qlik Technologies (Qlik) to Hold
93778
Pharmaxis shares dive after US review
101124
Morgan Stanley lowered its 2011 EPS estimate for Websense
21083
Research In Motion (rimm) downgraded at Morgan Stanley